https://www.arkansashealthcarereport.com/article/912884982-biosyent-declares-second-quarter-2026-dividend Arkansas Healthcare Report en PressRelease 2026-05-14T22:01:00+00:00 BioSyent Declares Second Quarter 2026 Dividend https://ml.globenewswire.com/media/3dded277-7953-4418-be63-7d7a3067811d/small/biosyent-logo-png.png https://www.arkansashealthcarereport.com/article/912885672-sol-sence-supports-landmark-report-on-uv-safety-in-the-united-kingdom-as-member-of-uv-safety-coalition Arkansas Healthcare Report en PressRelease 2026-05-14T22:00:29+00:00 Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition https://ml.globenewswire.com/media/0ce1f2dd-8447-4b3f-8f4f-18dcb6769641/medium/solesence-with-chair-of-appg-for-beauty-hair-wellbeing-and-t.jpg https://www.arkansashealthcarereport.com/article/912885636-biosyent-releases-financial-results-for-first-quarter-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T22:00:00+00:00 BioSyent Releases Financial Results for First Quarter 2026 https://ml.globenewswire.com/media/3dded277-7953-4418-be63-7d7a3067811d/small/biosyent-logo-png.png https://www.arkansashealthcarereport.com/article/912885616-glucotrack-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights Arkansas Healthcare Report en PressRelease 2026-05-14T21:27:07+00:00 Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights https://ml.globenewswire.com/media/bafad597-388b-4b55-bab1-535713ff1321/small/logo-png.png https://www.arkansashealthcarereport.com/article/912885540-lixte-biotechnology-files-first-quarter-2026-quarterly-report-on-form-10-q-provides-operational-progress-update Arkansas Healthcare Report en PressRelease 2026-05-14T21:18:00+00:00 LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update https://ml.globenewswire.com/media/7e828ef4-6c8f-4c94-b376-4e3749530fba/small/logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912885207-nuo-therapeutics-announces-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T21:15:00+00:00 Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/c9831d46-5ac9-4479-99e1-64169e0c24fd/small/nuo-therapeutics-jpg.jpg https://www.arkansashealthcarereport.com/article/912885479-netramark-provides-second-quarter-update-and-highlights-continued-commercial-scientific-regulatory-and-capital-markets-momentum Arkansas Healthcare Report en PressRelease 2026-05-14T21:00:57+00:00 NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum https://ml.globenewswire.com/media/d65cf3f8-cf9c-475c-b740-09a659269da4/small/netramark-word-eye-blk-jpg.jpg https://www.arkansashealthcarereport.com/article/912885005-precipio-announces-q1-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T21:00:00+00:00 Precipio Announces Q1 2026 Financial Results https://ml.globenewswire.com/media/d80ae417-b29a-4736-afa2-0f5e3beae51b/small/prpo-logo-png.png https://www.arkansashealthcarereport.com/article/912884917-edesa-biotech-reports-fiscal-2nd-quarter-2026-results Arkansas Healthcare Report en PressRelease 2026-05-14T20:30:00+00:00 Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results https://ml.globenewswire.com/media/36e957b9-bba2-48b4-a2ec-a471d945dcc4/small/logo-edesa-300dpi-r-jpg.jpg https://www.arkansashealthcarereport.com/article/912885017-healios-k-k-to-present-at-jefferies-global-healthcare-conference Arkansas Healthcare Report en PressRelease 2026-05-14T20:30:00+00:00 HEALIOS K.K. to Present at Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/f656f7b5-b076-47a8-8c3c-aa6280b1ef75/small/healios-logo-horizontal-black-jpg.jpg https://www.arkansashealthcarereport.com/article/912885054-medicus-pharma-reports-first-quarter-2026-financial-results-and-provides-corporate-update Arkansas Healthcare Report en PressRelease 2026-05-14T20:30:00+00:00 Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg https://www.arkansashealthcarereport.com/article/912885278-ocugen-inc-announces-closing-for-130-0-million-of-6-75-convertible-senior-notes Arkansas Healthcare Report en PressRelease 2026-05-14T20:30:00+00:00 Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png https://www.arkansashealthcarereport.com/article/912885326-hcw-biologics-reports-first-quarter-2026-business-highlights-and-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T20:25:00+00:00 HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results https://ml.globenewswire.com/media/5689edc3-6997-43a0-a20c-b34dc5f99b0f/small/hcw-logo-full-color-600x-jpeg-2-jpg.jpg https://www.arkansashealthcarereport.com/article/912864827-serina-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-updates Arkansas Healthcare Report en PressRelease 2026-05-14T20:20:00+00:00 Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/7f8e4304-8465-4d4d-a7e3-ebc4eae51f29/small/yellow-burts-blue-text-1-png.png https://www.arkansashealthcarereport.com/article/912864602-first-tracks-biotherapeutics-announces-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T20:15:00+00:00 First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/7165e7cf-d98b-4a0f-90f3-3cd8f3a6b320/small/ftb-logo-png.png https://www.arkansashealthcarereport.com/article/912864948-bio-green-med-solution-reports-first-quarter-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T20:15:00+00:00 BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE https://ml.globenewswire.com/media/45a5dcca-de5c-4b89-84dc-f86101550df7/small/new-logo-png.png https://www.arkansashealthcarereport.com/article/912865153-tempest-reports-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T20:15:00+00:00 Tempest Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg https://www.arkansashealthcarereport.com/article/912864596-cardiff-oncology-reports-first-quarter-2026-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T20:10:00+00:00 Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg https://www.arkansashealthcarereport.com/article/912864852-fortress-biotech-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights Arkansas Healthcare Report en PressRelease 2026-05-14T20:10:00+00:00 Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights https://ml.globenewswire.com/media/d82bf2ce-81b7-4989-9e6b-08e6bb6e1f95/small/fortressbio1-jpg.jpg https://www.arkansashealthcarereport.com/article/912864997-calidi-biotherapeutics-reports-first-quarter-2026-financial-results-and-recent-operational-highlights Arkansas Healthcare Report en PressRelease 2026-05-14T20:10:00+00:00 Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://www.arkansashealthcarereport.com/article/912865161-cue-biopharma-reports-first-quarter-2026-financial-results-and-recent-strategic-developments Arkansas Healthcare Report en PressRelease 2026-05-14T20:07:28+00:00 Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.arkansashealthcarereport.com/article/912863922-oculis-publishes-results-of-2026-annual-general-meeting-and-announces-election-of-gregory-d-perry-to-its-board-of-directors Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://www.arkansashealthcarereport.com/article/912864058-spyglass-pharma-reports-first-quarter-2026-financial-results-and-provides-corporate-updates Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates https://ml.globenewswire.com/media/fe0fc2c2-1623-4d3f-94bb-41782201a1e6/small/spyglass-pharma-logo-long-png.png https://www.arkansashealthcarereport.com/article/912864098-immucell-announces-unaudited-financial-results-for-the-quarter-ended-march-31-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/680330c2-368b-4abc-9429-878b0c9fb1a2/small/immucell-jpg.jpg https://www.arkansashealthcarereport.com/article/912864190-alumis-reports-first-quarter-2026-financial-results-and-highlights-recent-achievements Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 Alumis Reports First Quarter 2026 Financial Results and Highlights Recent Achievements https://ml.globenewswire.com/media/d91605d4-7524-4c20-ac0f-3ba880ef4fe6/small/alumis-png.png https://www.arkansashealthcarereport.com/article/912864280-zymeworks-announces-share-repurchase-program-of-up-to-125-million-of-its-common-stock Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png https://www.arkansashealthcarereport.com/article/912864311-sutro-biopharma-reports-first-quarter-2026-financial-results-and-business-highlights Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/b29d64ff-a5d8-41ff-9d46-e0e332cc7f28/small/image001-png.png https://www.arkansashealthcarereport.com/article/912864338-eton-pharmaceuticals-reports-first-quarter-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 Eton Pharmaceuticals Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png https://www.arkansashealthcarereport.com/article/912864364-jasper-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/ed6e5311-feff-4502-874f-39486c6ba17a/small/jasper-png.png https://www.arkansashealthcarereport.com/article/912864409-arcadia-biosciences-rkda-announces-first-quarter-2026-financial-results-and-business-highlights Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/14ddac08-5ef5-4fec-93f1-4191efdf4c33/small/arcadialogo-jpg.jpg https://www.arkansashealthcarereport.com/article/912864533-nurix-therapeutics-presents-new-preclinical-and-phase-1-translational-data-supporting-bexobrutideg-nx-5948-in-chronic-spontaneous-urticaria-at-the Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting https://ml.globenewswire.com/media/65f50366-0a4e-4329-b0f5-f737c6145524/small/new-primary-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912864544-elutia-reports-first-quarter-2026-results-and-highlights-nxt-41x-progress-toward-1-5-billion-u-s-plastic-and-reconstructive-surgery-market Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 Elutia Reports First Quarter 2026 Results and Highlights NXT-41x Progress Toward $1.5 Billion U.S. Plastic and Reconstructive Surgery Market https://ml.globenewswire.com/media/9818bf87-5594-4aae-aa0a-315674cd415b/small/elutia-hires-logo-1200x630-png.png https://www.arkansashealthcarereport.com/article/912864553-maplight-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/173b471e-5a67-4f12-84f2-06f4980ebd76/small/maplight-logo-horizontal-web-color-png.png https://www.arkansashealthcarereport.com/article/912864579-aeon-biopharma-reports-first-quarter-2026-financial-results-and-provides-corporate-update Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/c49be6f2-5e65-4a6d-9aef-e6b695554fb6/small/aeon-logo-png.png https://www.arkansashealthcarereport.com/article/912864666-avita-medical-reports-first-quarter-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 AVITA Medical Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://www.arkansashealthcarereport.com/article/912864790-nurexone-advances-to-stage-2-of-eu-backed-eit-health-catapult-programme-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 NurExone Advances to Stage 2 of EU-Backed EIT Health Catapult Programme 2026 https://ml.globenewswire.com/media/1514c671-cc84-4bcb-82d7-b834fce40882/small/nurexone-logo-rebrand-large-png.png https://www.arkansashealthcarereport.com/article/912864808-capsovision-reports-first-quarter-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 CapsoVision Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/3762c13c-02bc-43fe-85be-1808d440f15a/small/capsovision-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912864815-srx-health-solutions-announces-fiscal-second-quarter-2026-results-for-quarter-ended-march-31-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 SRx Health Solutions Announces Fiscal Second Quarter 2026 Results for Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/768807fe-a29b-48f5-be44-977c8eaf49f0/small/srxlogo-jpg.jpg https://www.arkansashealthcarereport.com/article/912864844-biostem-technologies-reports-first-quarter-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 BioStem Technologies Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/da0ea21a-fd6e-425a-a8f2-6f69dc2b4612/small/biostem-main-logo-png.png https://www.arkansashealthcarereport.com/article/912864971-renovorx-reports-record-first-quarter-2026-increasing-revenue-by-136-quarter-over-quarter Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter https://ml.globenewswire.com/media/e18bf823-ff44-4bbd-82b9-3a311d58dad8/small/final-logo-horizontal-png.png https://www.arkansashealthcarereport.com/article/912865016-artelo-biosciences-provides-business-update-outlining-upcoming-milestones-and-reports-2026-first-quarter-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T20:05:00+00:00 Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results https://ml.globenewswire.com/media/460502d7-b0d3-43d8-a15a-5b2bb963bbbb/small/artelo-jpg.jpg https://www.arkansashealthcarereport.com/article/912864158-alignment-health-plan-recognized-as-one-of-four-medicare-advantage-prescription-drug-plans-in-the-u-s-for-2026-excellence-in-quality Arkansas Healthcare Report en PressRelease 2026-05-14T20:01:00+00:00 Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality https://ml.globenewswire.com/media/c6122501-032d-4425-bb0d-759ee3d3fe68/small/alignmenthealthcare-primary-logo-verticala-png.png https://www.arkansashealthcarereport.com/article/912864202-dar-bioscience-reports-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T20:01:00+00:00 Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/deaaf9ba-24cc-4909-ab8d-1982b8b4e650/small/darebioscience-primarylogo-02-vertical-reg-orangebrown-wtrad.png https://www.arkansashealthcarereport.com/article/912864240-macrogenics-to-participate-in-the-stifel-2026-virtual-targeted-oncology-forum Arkansas Healthcare Report en PressRelease 2026-05-14T20:01:00+00:00 MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum https://ml.globenewswire.com/media/9b9481ff-ca9f-4a5a-aa38-0ff57a087856/small/macrogenics-logo-rgb-fullcolor-png.png https://www.arkansashealthcarereport.com/article/912864270-elutia-to-present-at-the-16th-annual-ld-micro-invitational-on-may-18th Arkansas Healthcare Report en PressRelease 2026-05-14T20:01:00+00:00 Elutia to Present at the 16th Annual LD Micro Invitational on May 18th https://ml.globenewswire.com/media/9818bf87-5594-4aae-aa0a-315674cd415b/small/elutia-hires-logo-1200x630-png.png https://www.arkansashealthcarereport.com/article/912864416-heartflow-reports-first-quarter-2026-financial-results-and-raises-full-year-2026-guidance Arkansas Healthcare Report en PressRelease 2026-05-14T20:01:00+00:00 Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance https://ml.globenewswire.com/media/c6be111e-2f8e-4ac8-8fa8-310dbcbd6e15/small/25-1113-cmyk-hf-logo-positive-png.png https://www.arkansashealthcarereport.com/article/912864462-sangamo-therapeutics-reports-recent-business-highlights-and-first-quarter-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T20:01:00+00:00 Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results https://ml.globenewswire.com/media/e3084490-aff3-4c15-8036-d94123563fd0/small/sangamo-logotm-11-11zon-png.png https://www.arkansashealthcarereport.com/article/912864530-celcuity-inc-reports-release-of-first-quarter-2026-financial-results-and-provides-corporate-update Arkansas Healthcare Report en PressRelease 2026-05-14T20:01:00+00:00 Celcuity Inc. Reports Release of First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/dab74495-313f-47dd-a6cb-b42a7f024edd/small/celcuity-logo-rgb-jpg.jpg https://www.arkansashealthcarereport.com/article/912864824-aardvark-therapeutics-plans-to-unblind-hero-and-ole-data-to-inform-path-forward-following-fda-clinical-hold Arkansas Healthcare Report en PressRelease 2026-05-14T20:01:00+00:00 Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold https://ml.globenewswire.com/media/8fed323c-8d04-4a71-bfb1-e38d23a29ec9/small/aardvark-logo-png.png https://www.arkansashealthcarereport.com/article/912864153-adcare-rhode-island-among-few-in-the-northeast-offering-accelerated-methadone-detox Arkansas Healthcare Report en PressRelease 2026-05-14T19:30:00+00:00 AdCare Rhode Island Among Few in the Northeast Offering Accelerated Methadone Detox https://ml.globenewswire.com/media/d184b31a-2896-48dd-8479-fc5c8cfc4b98/small/rhode-island-png.png https://www.arkansashealthcarereport.com/article/912864609-pruitthealth-certified-as-a-great-place-to-work-for-fifth-consecutive-year Arkansas Healthcare Report en PressRelease 2026-05-14T18:28:22+00:00 PruittHealth Certified as a Great Place to Work for Fifth Consecutive Year https://ml.globenewswire.com/media/NmNhYTU4YjgtMzI0Zi00MDBmLTk3OGEtZTNmNjRhZmFjYjVhLTUwMDEyNDk5Ny0yMDI2LTA1LTE0LWVu/tiny/PruittHealth.png https://www.arkansashealthcarereport.com/article/912844662-historical-dna-connects-1-3-million-living-relatives-to-17th-century-maryland-settlers-and-may-have-identified-the-colony-s-second-governor Arkansas Healthcare Report en PressRelease 2026-05-14T18:16:01+00:00 Historical DNA connects 1.3 million living relatives to 17th-century Maryland settlers and may have identified the colony’s second governor https://ml.globenewswire.com/media/e614a219-c44d-4fb3-8c94-b3a330509af9/small/23andme-ri-logo-stacked-color-min-png.png https://www.arkansashealthcarereport.com/article/912844383-monopar-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-updates Arkansas Healthcare Report en PressRelease 2026-05-14T18:00:00+00:00 Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/f8cee181-5ae9-4a02-84f5-6e35affbb72b/small/monopartherapeuticsinc-png.png https://www.arkansashealthcarereport.com/article/912844486-award-winning-film-an-inconvenient-study-being-blocked-by-verizon Arkansas Healthcare Report en PressRelease 2026-05-14T17:11:17+00:00 Award-Winning Film ‘An Inconvenient Study’ Being Blocked By Verizon https://ml.globenewswire.com/media/a54a2267-559c-40aa-a5c4-a3f643889edf/medium/an-inconvenient-study-film-censored.png https://www.arkansashealthcarereport.com/article/912844427-adaptin-bio-shares-ticker-aptn-commence-trading-on-the-otcqb Arkansas Healthcare Report en PressRelease 2026-05-14T17:05:00+00:00 Adaptin Bio Shares (Ticker: APTN) Commence Trading on the OTCQB https://ml.globenewswire.com/media/89fb59f4-0171-4319-995d-70be0b36378b/small/logo-png.png https://www.arkansashealthcarereport.com/article/912825650-rarecells-recognized-among-top-5-disruptive-health-technologies-with-the-potential-to-change-the-world-by-maynooth-university-s-innovation-value Arkansas Healthcare Report en PressRelease 2026-05-14T16:11:34+00:00 Rarecells Recognized Among Top 5 Disruptive Health Technologies with the Potential to Change the World by Maynooth University’s Innovation Value Institute https://ml.globenewswire.com/media/5588dca9-da40-464a-8996-c719a9bee2ca/small/rarecells-logo-horizontal-apple-pixels-jpg.jpg https://www.arkansashealthcarereport.com/article/912825550-imviva-biotech-presents-data-demonstrating-durable-clinical-responses-from-ongoing-phase-1-2-study-of-cta313-in-systemic-lupus-erythematosus-at-asgct Arkansas Healthcare Report en PressRelease 2026-05-14T15:43:11+00:00 Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026 https://ml.globenewswire.com/media/YTAyNGM0NGQtNjE0YS00ZmY2LTgxZTktNWRjZjY3M2QzZDM4LTEzMTkxMjUtMjAyNi0wNS0xNC1lbg==/tiny/Imviva-US-Holdings-LLC.png https://www.arkansashealthcarereport.com/article/912825475-terumo-neuro-announces-publication-of-landmark-rage-study-results-for-hydrocoil-embolic-system-coils-for-ruptured-intracranial-aneurysms Arkansas Healthcare Report en PressRelease 2026-05-14T15:29:00+00:00 Terumo Neuro Announces Publication of Landmark RAGE Study Results for HydroCoil™ Embolic System Coils for Ruptured Intracranial Aneurysms https://ml.globenewswire.com/media/77b40a48-c770-4600-818c-6f439e907635/medium/hydrocoil-embolic-system-hes-coil.png https://www.arkansashealthcarereport.com/article/912825138-zealand-pharma-transactions-related-to-share-buy-back-program-weeks-19-20-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T15:00:00+00:00 Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026) https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.arkansashealthcarereport.com/article/912825139-dentprime-introduces-an-international-complication-protection-program-for-overseas-dental-patients Arkansas Healthcare Report en PressRelease 2026-05-14T15:00:00+00:00 DentPrime Introduces an “International Complication Protection Program” for Overseas Dental Patients https://ml-eu.globenewswire.com/media/c57ccc06-c02e-4c03-b86d-4593a4e1a489/medium/dentprime-dental-treatment-room.jpg https://www.arkansashealthcarereport.com/article/912825406-oryzon-reports-financial-results-and-corporate-update-for-quarter-ended-march-31st-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T14:47:26+00:00 ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026 https://ml.globenewswire.com/media/56e13ce4-e7d9-45ee-85e9-26feec9b7c6f/small/logo-png.png https://www.arkansashealthcarereport.com/article/912825196-global-digital-stethoscopes-market-set-to-reach-usd-717-3-million-by-2032-marketsandmarkets Arkansas Healthcare Report en PressRelease 2026-05-14T14:45:00+00:00 Global Digital Stethoscopes Market Set to Reach USD 717.3 Million by 2032 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.arkansashealthcarereport.com/article/912825350-incannex-healthcare-officially-commences-dreamzz-clinical-study-for-ihl-42x-in-obstructive-sleep-apnea Arkansas Healthcare Report en PressRelease 2026-05-14T14:35:00+00:00 Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea https://ml.globenewswire.com/media/f484ac33-560c-412b-ba64-c65ac174d6f8/small/incannex-positive-png.png https://www.arkansashealthcarereport.com/article/912807389-tessera-therapeutics-showcases-new-preclinical-data-advancing-in-vivo-program-in-sickle-cell-disease-and-car-t-applications-at-the-american-society-of Arkansas Healthcare Report en PressRelease 2026-05-14T14:20:08+00:00 Tessera Therapeutics Showcases New Preclinical Data Advancing In Vivo Program in Sickle Cell Disease and CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting https://ml.globenewswire.com/media/f24875fb-efec-43e6-8b98-2da3edea398a/small/picture1-jpg.jpg https://www.arkansashealthcarereport.com/article/912805988-nfl-hall-of-famer-brett-favre-reports-significant-parkinson-s-medication-reduction-as-zhittya-genesis-medicine-marks-four-years-of-parkinson-s Arkansas Healthcare Report en PressRelease 2026-05-14T14:00:00+00:00 NFL Hall of Famer Brett Favre Reports Significant Parkinson's Medication Reduction as Zhittya Genesis Medicine Marks Four Years of Parkinson’s Research https://ml.globenewswire.com/media/e6ea355a-59fa-454d-9dbf-68a035fc324a/small/zhittya-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912806035-red-ribbon-recovery-colorado-now-offers-virtual-addiction-treatment-to-patients-across-the-united-states Arkansas Healthcare Report en PressRelease 2026-05-14T14:00:00+00:00 Red Ribbon Recovery Colorado now offers virtual addiction treatment to patients across the United States https://ml.globenewswire.com/media/fcfa5e64-dc1c-4554-bc72-b2a43545a471/small/red-ribbon-recovery-colorado-alcohol-and-drug-treatment-logo.png https://www.arkansashealthcarereport.com/article/912806102-inner-voyage-recovery-center-launches-virtual-intensive-outpatient-program-for-georgia-and-beyond Arkansas Healthcare Report en PressRelease 2026-05-14T14:00:00+00:00 Inner Voyage Recovery Center launches virtual intensive outpatient program for Georgia and beyond https://ml.globenewswire.com/media/e9f64f34-ec8b-46b5-988e-6054ebdfd330/small/inner-voyage-recovery-center-atlanta-drug-rehab-logo.jpg https://www.arkansashealthcarereport.com/article/912806118-lanier-recovery-center-opens-its-doors-in-suwanee-georgia-bringing-comprehensive-addiction-treatment-to-the-atlanta-region Arkansas Healthcare Report en PressRelease 2026-05-14T14:00:00+00:00 Lanier Recovery Center opens its doors in Suwanee, Georgia, bringing comprehensive addiction treatment to the Atlanta region https://ml.globenewswire.com/media/2fa0e30f-5931-4ebc-8f8e-7a0aadc22d3d/small/lanier-recovery-center-drug-rehab-atlanta-logo.png https://www.arkansashealthcarereport.com/article/912805925-silexion-therapeutics-reports-positive-preliminary-immunotherapy-findings-for-sil204-in-kras-driven-pancreatic-cancer Arkansas Healthcare Report en PressRelease 2026-05-14T13:27:00+00:00 Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer https://ml-eu.globenewswire.com/Resource/Download/d79e68e5-cf6d-46e7-bc32-876e03e37f33/screenshot-2026-05-14-at-13-47-48.png https://www.arkansashealthcarereport.com/article/912807119-tomi-environmental-solutions-inc-announces-second-steramist-hybrid-system-installation-contract-with-a-world-renowned-east-coast-research-university Arkansas Healthcare Report en PressRelease 2026-05-14T13:20:00+00:00 TOMI Environmental Solutions, Inc. Announces Second SteraMist Hybrid System Installation Contract with a World-Renowned East Coast Research University https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.arkansashealthcarereport.com/article/912806790-polaryx-therapeutics-receives-ghp-magazine-s-healthcare-pharmaceuticals-awards Arkansas Healthcare Report en PressRelease 2026-05-14T13:15:00+00:00 Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards https://ml.globenewswire.com/media/64e2f507-40e8-46aa-b22e-6661e7035467/small/polaryx-logonew-png.png https://www.arkansashealthcarereport.com/article/912806369-sonablate-launches-sona-fusion-global-registry-to-advance-precision-sound-medicine-and-define-future-standards-in-focal-therapy Arkansas Healthcare Report en PressRelease 2026-05-14T13:03:00+00:00 Sonablate Launches SONA FUSION Global Registry to Advance Precision Sound Medicine and Define Future Standards in Focal Therapy https://ml.globenewswire.com/media/64db807c-9ef4-4759-950c-34c3ef3d84a2/medium/sona-fusion-registry.png https://www.arkansashealthcarereport.com/article/912806366-cj-biomaterials-launches-new-home-compostable-all-pha-extrusion-coating-resin-for-paper-food-serviceware Arkansas Healthcare Report en PressRelease 2026-05-14T13:00:00+00:00 CJ Biomaterials Launches New Home Compostable all-PHA Extrusion Coating Resin for Paper Food Serviceware https://ml.globenewswire.com/media/5dbaaccd-ff7a-4d66-8c07-19059a6bd89e/medium/compostable-coffee-cup.jpg https://www.arkansashealthcarereport.com/article/912807090-syneos-health-expands-strategic-ai-partnerships-to-advance-commercial-precision-performance Arkansas Healthcare Report en PressRelease 2026-05-14T13:00:00+00:00 Syneos Health Expands Strategic AI Partnerships to Advance Commercial Precision Performance https://ml.globenewswire.com/media/6b3b2435-841a-44d4-becd-d8625ca90975/small/syneos-health-rgb-r-jpg.jpg https://www.arkansashealthcarereport.com/article/912807081-curanex-reports-first-quarter-2026-business-progress-as-phyto-n-advances-toward-planned-fda-submission Arkansas Healthcare Report en PressRelease 2026-05-14T12:53:00+00:00 Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission https://ml.globenewswire.com/media/29bc3de5-6a82-4a17-a165-6a79eef16d74/small/logo-png.png https://www.arkansashealthcarereport.com/article/912806072-administrative-experience-emerges-as-key-pressure-point-for-self-funded-plans-brighton-health-plan-solutions-survey-finds Arkansas Healthcare Report en PressRelease 2026-05-14T12:45:00+00:00 Administrative Experience Emerges as Key Pressure Point for Self-Funded Plans, Brighton Health Plan Solutions Survey Finds https://ml.globenewswire.com/media/77989f85-347a-4667-ac3f-7253e09a0056/small/bhps-brighter-campaign-logo-04-2024-png.png https://www.arkansashealthcarereport.com/article/912806497-senti-biosciences-holdings-reports-first-quarter-2026-financial-results-and-highlights-advancement-of-senti-202-program-into-pivotal-phase Arkansas Healthcare Report en PressRelease 2026-05-14T12:45:00+00:00 Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase https://ml.globenewswire.com/media/19732ef2-d354-4281-9dc5-6000f190dd83/small/sentibiologo-jpg.jpg https://www.arkansashealthcarereport.com/article/912806260-aim-immunotech-posts-virtual-investor-key-opinion-leader-segment-spotlighting-ampligen-breakthrough-data-in-pancreatic-cancer Arkansas Healthcare Report en PressRelease 2026-05-14T12:41:00+00:00 AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer https://ml.globenewswire.com/media/02a464b0-e3c7-41fd-bc8f-259f5833a8d6/medium/professor-casper-h-j-van-eijck-md-phd.jpg https://www.arkansashealthcarereport.com/article/912806325-easy-environmental-solutions-terreplenish-show-outstanding-yield-increases-offer-alternative-to-petroleum-based-fertilizers Arkansas Healthcare Report en PressRelease 2026-05-14T12:40:00+00:00 Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers https://ml.globenewswire.com/media/c10d522b-70c9-4eb6-b7a4-b0d4f808aea1/medium/terreplenish-treated-rice-field-in-ghana.png https://www.arkansashealthcarereport.com/article/912806522-senti-biosciences-holdings-announces-positive-fda-rmat-meeting-on-registrational-clinical-and-cmc-strategy-for-senti-202-in-relapsed-refractory-aml Arkansas Healthcare Report en PressRelease 2026-05-14T12:40:00+00:00 Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program https://ml.globenewswire.com/media/aae7bc52-613b-4390-92fc-de95dd361d1f/medium/survival-curve.jpg https://www.arkansashealthcarereport.com/article/912806357-gri-bio-reports-first-quarter-2026-financial-results-new-data-reinforcing-differentiated-profile-of-gri-0621-in-idiopathic-pulmonary-fibrosis-and Arkansas Healthcare Report en PressRelease 2026-05-14T12:35:00+00:00 GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline https://ml.globenewswire.com/media/b867302d-b18d-4ab0-9fc0-919daecec8be/small/logo-png.png https://www.arkansashealthcarereport.com/article/912806984-biogen-completes-acquisition-of-apellis-pharmaceuticals Arkansas Healthcare Report en PressRelease 2026-05-14T12:35:00+00:00 Biogen Completes Acquisition of Apellis Pharmaceuticals https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://www.arkansashealthcarereport.com/article/912787859-20-20-biolabs-to-attend-sidoti-micro-cap-virtual-conference-on-may-20-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T12:31:00+00:00 20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026 https://ml.globenewswire.com/media/bcaf95ca-9983-408c-bc61-646e4ee2f925/small/2020-biolabs-logo-png.png https://www.arkansashealthcarereport.com/article/912786512-biodexa-issues-letter-to-shareholders Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 Biodexa issues letter to Shareholders https://ml-eu.globenewswire.com/media/8367259c-e117-4264-9988-26f7e36b032f/small/biodexa-logo-square-1-png.png https://www.arkansashealthcarereport.com/article/912786606-milestone-pharmaceuticals-to-present-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png https://www.arkansashealthcarereport.com/article/912787014-dogwood-therapeutics-announces-first-quarter-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 Dogwood Therapeutics Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/7fe5cc47-6599-477c-a858-0f0d9b9f7eb5/small/green-and-gray-png.png https://www.arkansashealthcarereport.com/article/912787051-fda-approves-new-dosing-option-for-crysvita-burosumab-twza-in-adults-with-xlh Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 FDA Approves New Dosing Option for CRYSVITA® (burosumab-twza) in Adults With XLH https://ml.globenewswire.com/media/a3a8a24d-ccff-49c4-baf1-bf8e8a7a2551/small/img-ogp-1755267550540-png.png https://www.arkansashealthcarereport.com/article/912787082-tarsus-and-john-cena-partner-to-raise-awareness-of-demodex-blepharitis-a-common-eyelid-disease-affecting-approximately-25-million-americans Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans https://ml.globenewswire.com/media/c32bcd98-15c8-4c2e-9e1d-95ffe74aa94c/medium/john-cena.jpg https://www.arkansashealthcarereport.com/article/912787185-gt-biopharma-announces-first-patient-dosed-in-phase-1-trial-of-gtb-5550-a-b7-h3-targeted-natural-killer-nk-cell-engager-for-solid-tumors Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors https://ml.globenewswire.com/media/d185929e-a134-45e9-beed-5895b902fd3e/small/logo-png.png https://www.arkansashealthcarereport.com/article/912787448-microbot-medical-successfully-transitions-to-commercial-operations-as-it-records-revenue-resulting-from-its-limited-market-release-during-the-first Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026 https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://www.arkansashealthcarereport.com/article/912787555-capehaven-completes-first-close-of-funding-and-initiates-operations-to-encourage-yale-s-biotech-spinouts Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 CapeHaven Completes First Close of Funding and Initiates Operations to Encourage Yale’s Biotech Spinouts https://ml.globenewswire.com/media/4ab7b6ee-0875-415c-9578-4343bb2d5df6/small/capehavenlogo-002-jpg.jpg https://www.arkansashealthcarereport.com/article/912787850-oncotelic-therapeutics-inc-otcqb-otlc-responds-to-bbb-challenge-with-next-gen-drug-delivery-platform Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 Oncotelic Therapeutics Inc. (OTCQB: OTLC) Responds to BBB Challenge with Next-Gen Drug-Delivery Platform https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.arkansashealthcarereport.com/article/912787856-surenano-science-ltd-cse-sure-otcqb-surnf-developing-distinct-next-gen-glp-1-built-around-novel-peptide Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Developing Distinct Next-Gen GLP-1 Built Around Novel Peptide https://ml.globenewswire.com/media/4e983dfa-f169-46a5-ba21-ed1d05a90830/small/surenano-logo-png.png https://www.arkansashealthcarereport.com/article/912787868-mindbio-therapeutics-corp-cse-mbio-otcqb-mbqif-harnesses-key-ai-voice-analysis-to-offer-impairment-solution Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Harnesses Key AI, Voice Analysis to Offer Impairment Solution https://ml.globenewswire.com/media/ef429fe7-9cc2-4785-8e91-97fe534a4cd1/small/mbio-2048x537-png.png https://www.arkansashealthcarereport.com/article/912788087-vor-bio-announces-publication-of-interim-analysis-of-teligan-a-china-phase-3-trial-of-telitacicept-in-iga-nephropathy-in-the-new-england-journal-of Arkansas Healthcare Report en PressRelease 2026-05-14T12:30:00+00:00 Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png https://www.arkansashealthcarereport.com/article/912786615-candel-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights Arkansas Healthcare Report en PressRelease 2026-05-14T12:05:00+00:00 Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://www.arkansashealthcarereport.com/article/912788222-prenetics-welcomes-brian-j-rosin-as-chief-financial-officer-of-im8 Arkansas Healthcare Report en PressRelease 2026-05-14T12:05:00+00:00 Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8 https://ml.globenewswire.com/media/106dbe1a-a6e1-49d9-97a2-c5609258bdc7/small/pre-logo-2026-png.png https://www.arkansashealthcarereport.com/article/912786507-organox-announces-appointment-of-naoya-iwata-as-ceo-president Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 OrganOx Announces Appointment of Naoya Iwata as CEO & President https://ml-eu.globenewswire.com/media/4a1ef753-3211-41f5-975d-9f11e10ff44b/small/organox-clr-png.png https://www.arkansashealthcarereport.com/article/912786613-inmune-bio-receives-fda-fast-track-designation-for-xpro1595-in-early-alzheimer-s-disease Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease https://ml.globenewswire.com/media/64035ec0-9fc2-414d-a693-27f1b1e90a31/small/logo-png.png https://www.arkansashealthcarereport.com/article/912786627-koelis-announces-promap-smart-automatic-prostate-contouring-software-at-aua-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Koelis Announces ProMap® Smart Automatic Prostate Contouring Software at AUA 2026 https://ml.globenewswire.com/media/16c755c2-866a-45d2-a453-e5f4483f6657/medium/new-promap-smart-auto-contouring.jpeg https://www.arkansashealthcarereport.com/article/912786639-kyverna-therapeutics-to-present-at-upcoming-investor-conferences Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Kyverna Therapeutics to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.arkansashealthcarereport.com/article/912786697-keros-therapeutics-reports-recent-first-quarter-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Keros Therapeutics Reports Recent First Quarter 2026 Financial Results https://ml.globenewswire.com/media/baf5be5e-8ec5-4b74-8950-e28c4888b29c/small/keros-2-jpg.jpg https://www.arkansashealthcarereport.com/article/912786899-menarini-group-announces-new-data-at-the-american-society-of-clinical-oncology-asco-2026-annual-meeting Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting https://ml.globenewswire.com/media/e37a0bbd-9120-49d8-b6d5-ba5fbdd58ed8/small/menarini-stemline-logo-png.png https://www.arkansashealthcarereport.com/article/912786919-forward-therapeutics-announces-completion-of-phase-1-trials-with-two-internally-discovered-next-generation-tnf-signaling-inhibitors-supporting Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Forward Therapeutics Announces Completion of Phase 1 Trials with Two Internally Discovered Next-Generation TNF Signaling Inhibitors Supporting Advancement to Phase 2 Clinical Development https://ml.globenewswire.com/media/ef01fb1a-692f-4944-8f46-d9808bc68475/small/logo-forward-therapeutics-rgb-high-res-png.png https://www.arkansashealthcarereport.com/article/912787064-aua-guidelines-strengthen-recommendation-for-aquablation-therapy Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 AUA Guidelines Strengthen Recommendation for Aquablation® Therapy https://ml.globenewswire.com/media/fc9b1b79-13a0-4245-a974-081e3ceaafcb/small/procept-logo-png.PNG https://www.arkansashealthcarereport.com/article/912787069-cingulate-inc-reports-first-quarter-2026-financial-results-and-provides-an-update-of-commercial-readiness-efforts-on-track-for-lead-adhd-asset Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301 https://ml.globenewswire.com/media/61f4cd24-74d3-4103-b8f8-a768ef66e0ec/small/cingulate-logo-400x400-twitter-jpg.jpg https://www.arkansashealthcarereport.com/article/912787108-apyx-medical-corporation-announces-retrospective-clinical-publication-evaluating-clinical-benefit-of-renuvion-used-in-combination-with-liposuction Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction https://ml.globenewswire.com/media/aa0687d3-ab28-4615-b1e7-ef6c6e2a5541/small/apyx-medical-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912787144-in8bio-presents-new-translational-data-demonstrating-deltex-dri-reshapes-the-immune-landscape-in-glioblastoma Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma https://ml.globenewswire.com/media/ab4056e8-16d0-4c44-9ee8-367a47f6ef78/small/in8biologo-jpg.jpg https://www.arkansashealthcarereport.com/article/912787156-clene-reports-first-quarter-2026-financial-results-and-recent-operating-highlights Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png https://www.arkansashealthcarereport.com/article/912787160-pharmazz-inc-appoints-ajay-bansal-as-chief-financial-officer Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer https://ml.globenewswire.com/media/7f65d92a-551d-498b-af50-f40190b3b5df/small/pharmazz-logo-png.png https://www.arkansashealthcarereport.com/article/912787195-chemomab-therapeutics-announces-first-quarter-2026-financial-results-and-provides-corporate-update Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png https://www.arkansashealthcarereport.com/article/912787283-benitec-biopharma-releases-third-quarter-2026-financial-results-and-provides-operational-update Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update https://ml.globenewswire.com/media/627c78fb-57b8-41c6-89da-62599af40dd1/small/logo-png.png https://www.arkansashealthcarereport.com/article/912787373-corbus-pharmaceuticals-appoints-pharma-industry-veteran-brent-pfeiffenberger-to-board-of-directors Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912787504-brain-cancer-canada-invests-75-000-in-groundbreaking-phase-2-clinical-trial-at-sunnybrook-health-sciences-centre-to-target-hard-to-treat-glioblastoma Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Brain Cancer Canada Invests $75,000 in Groundbreaking Phase 2 Clinical Trial at Sunnybrook Health Sciences Centre to Target Hard-to-Treat Glioblastoma in Older Patients https://ml.globenewswire.com/media/78a73b7f-a470-42a5-9976-aa425939a68b/small/bcc-logo-2024-png.png https://www.arkansashealthcarereport.com/article/912787518-cvrx-announces-humana-medicare-advantage-coverage-policy-for-barostim-therapy Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png https://www.arkansashealthcarereport.com/article/912787759-sellas-life-sciences-to-participate-in-upcoming-investor-conferences Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 SELLAS Life Sciences to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/4ff07596-ddcc-4df5-be2f-e31a35217739/small/sellas-logo-png.png https://www.arkansashealthcarereport.com/article/912788120-synergy-chc-corp-reports-first-quarter-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Synergy CHC Corp. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/e0c31e7c-6700-4800-a664-800eefcd7518/small/synergy-png.png https://www.arkansashealthcarereport.com/article/912788160-prenetics-announces-preliminary-record-q1-2026-results-with-im8-revenue-growing-nearly-6x-yoy-company-raises-full-year-2026-im8-revenue-guidance-to Arkansas Healthcare Report en PressRelease 2026-05-14T12:00:00+00:00 Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M https://ml.globenewswire.com/media/106dbe1a-a6e1-49d9-97a2-c5609258bdc7/small/pre-logo-2026-png.png https://www.arkansashealthcarereport.com/article/912786562-legal-steroids-for-beginners-2026-muscle-growth-and-fat-loss-crazy-bulk-launched-safest-legal-steroid-alternatives-without-side-effects-in-usa Arkansas Healthcare Report en PressRelease 2026-05-14T11:32:49+00:00 Legal Steroids for Beginners 2026: (Muscle Growth And Fat Loss) Crazy Bulk Launched Safest Legal Steroid Alternatives Without Side Effects In USA. https://ml-eu.globenewswire.com/Resource/Download/fd6fb027-4c71-48cc-bda0-83c324f0e113/image4.jpeg https://www.arkansashealthcarereport.com/article/912786495-edap-focal-one-and-telix-announce-collaboration-focused-on-robotic-hifu-and-theranostics-in-prostate-cancer Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer https://ml-eu.globenewswire.com/media/ded19329-9645-4860-ac2d-bf3e2422b649/small/focalone-square-logo-drkblue-web-400-1-png.png https://www.arkansashealthcarereport.com/article/912786500-agomab-to-participate-in-upcoming-conferences Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 Agomab to Participate in Upcoming Conferences https://ml-eu.globenewswire.com/media/7f797bcb-5d5d-4fb6-a862-b5c861b83e54/small/agomab-logo-png.png https://www.arkansashealthcarereport.com/article/912786689-cytokinetics-to-host-annual-symposium-on-contemporary-landscapes-in-muscle-biology-climb Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB) https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.arkansashealthcarereport.com/article/912786814-nuvectis-pharma-inc-to-participate-in-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ https://ml.globenewswire.com/media/aceda01c-bc94-4579-88fa-c0294406b49f/small/nuvectispharma-logos-final-full-color-png.png https://www.arkansashealthcarereport.com/article/912786925-cognition-therapeutics-receives-second-philanthropic-donation-to-extend-ongoing-expanded-access-program-for-zervimesine-ct1812-in-dementia-with-lewy Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies https://ml.globenewswire.com/media/a14fd627-7ccb-45e2-95fe-792bbfb83231/small/2020-0227-cognition-logo-for-gnw-png.png https://www.arkansashealthcarereport.com/article/912787101-elevatebio-data-at-asgct-29th-annual-meeting-showcase-expanded-gene-editing-platform-and-services-spanning-new-modalities-ai-discovery-and-lnp Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 ElevateBio Data at ASGCT 29th Annual Meeting Showcase Expanded Gene Editing Platform and Services Spanning New Modalities, AI Discovery, and LNP Delivery https://ml.globenewswire.com/media/42238eb2-fd1c-4189-bf14-c7026687de5b/small/elevatebiologo-jpg.jpg https://www.arkansashealthcarereport.com/article/912787134-briacell-completes-manufacturing-of-clinical-supplies-of-bria-pros-for-prostate-cancer Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer https://ml.globenewswire.com/media/88b9408d-31d4-4afd-beff-f855719a15d8/small/briacell-logo-square-a-jpg.jpg https://www.arkansashealthcarereport.com/article/912787153-milestone-scientific-reports-financial-results-for-first-quarter-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 Milestone Scientific Reports Financial Results for First Quarter 2026 https://ml.globenewswire.com/media/408ad3c5-6ad3-41bd-9763-356666216796/small/milestonelogo-rgb-final-jpg.jpg https://www.arkansashealthcarereport.com/article/912787196-cormedix-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/a14d732c-3f66-4a3c-96bb-7fc8ba5797bb/small/crmd-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912787338-hcw-biologics-discovers-that-hcw11-040-prevents-bronchopulmonary-dysplasia-bpd-during-ind-enabling-studies Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies https://ml.globenewswire.com/media/5689edc3-6997-43a0-a20c-b34dc5f99b0f/small/hcw-logo-full-color-600x-jpeg-2-jpg.jpg https://www.arkansashealthcarereport.com/article/912787351-avicanna-reports-q1-2026-financial-statements Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 Avicanna Reports Q1 2026 Financial Statements https://ml.globenewswire.com/media/c9abc2f4-efdc-40f6-921d-a5da048eda46/small/avicanna-logo-colour-withtm-01-png.png https://www.arkansashealthcarereport.com/article/912787574-mink-therapeutics-and-first-lviv-territorial-medical-union-initiate-randomized-phase-2-trial-of-agent-797-in-acute-lung-injury-and-critical-illness Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://www.arkansashealthcarereport.com/article/912787823-celcuity-s-phase-3-viktoria-2-trial-of-gedatolisib-as-a-first-line-treatment-for-hr-her2-advanced-breast-cancer-expanding-to-include Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 Celcuity’s Phase 3 VIKTORIA-2 Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer Expanding to Include Endocrine-Sensitive Patients https://ml.globenewswire.com/media/dab74495-313f-47dd-a6cb-b42a7f024edd/small/celcuity-logo-rgb-jpg.jpg https://www.arkansashealthcarereport.com/article/912787932-biofrontera-inc-reports-first-quarter-2026-financial-results-and-provides-a-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T11:30:00+00:00 Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update https://ml.globenewswire.com/media/4af5197e-340e-4307-892b-382a1d29ae45/small/logo-png.png https://www.arkansashealthcarereport.com/article/912787217-cellectar-biosciences-reports-first-quarter-2026-financial-results-and-provides-corporate-updates Arkansas Healthcare Report en PressRelease 2026-05-14T11:15:00+00:00 Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates https://ml.globenewswire.com/media/980abc5d-826f-4ac3-ad81-f07d69b34af6/small/cellectar-logo-1-jpg.jpg https://www.arkansashealthcarereport.com/article/912787140-cabaletta-bio-reports-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T11:05:00+00:00 Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/44175396-6bbb-435f-b037-54a4052160d4/small/cabaletta-bio-registered-logo-png.png https://www.arkansashealthcarereport.com/article/912786851-invivyd-reports-first-quarter-2026-financial-results-and-recent-business-highlights Arkansas Healthcare Report en PressRelease 2026-05-14T11:01:00+00:00 Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png https://www.arkansashealthcarereport.com/article/912786913-asha-and-hilarity-for-charity-collaborate-in-free-online-event-for-dementia-caregivers-on-may-20 Arkansas Healthcare Report en PressRelease 2026-05-14T11:01:00+00:00 ASHA and Hilarity for Charity Collaborate in Free, Online Event for Dementia Caregivers on May 20 https://ml.globenewswire.com/media/0b30a6e0-a4e8-4f72-9a21-c481023bb282/small/ https://www.arkansashealthcarereport.com/article/912786496-indivior-to-participate-in-upcoming-investor-conferences Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Indivior to Participate in Upcoming Investor Conferences https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912786509-4basebio-announces-appointment-of-chief-financial-officer-and-board-changes Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 4basebio Announces Appointment of Chief Financial Officer and Board Changes https://ml-eu.globenewswire.com/media/b4cdfb28-5792-4f0a-b80f-b960556fe025/small/4basebio-logo-1-png.png https://www.arkansashealthcarereport.com/article/912786634-tonix-pharmaceuticals-to-present-retrospective-u-s-real-world-claims-analysis-characterizing-patients-with-fibromyalgia-at-ispor-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026 https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://www.arkansashealthcarereport.com/article/912786644-eyepoint-announces-third-consecutive-positive-dsmc-recommendation-for-phase-3-wet-amd-trials-for-duravyu-building-confidence-ahead-of-mid-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg https://www.arkansashealthcarereport.com/article/912786703-aveanna-healthcare-holdings-announces-first-quarter-financial-results-and-revised-2026-guidance Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance https://ml.globenewswire.com/media/d3896f9e-a6a1-48c1-a8f7-d9ba5d7433d6/small/aveanna-healthcare-500x262-png.png https://www.arkansashealthcarereport.com/article/912786855-brewdog-shakes-up-rtd-shelves-across-the-uk-with-new-nostalgia-led-wonderland-cocktails Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 BrewDog Shakes Up RTD Shelves Across the UK with New Nostalgia-Led Wonderland Cocktails https://ml.globenewswire.com/media/14b5b8d2-e9b8-4e70-915e-3863b46c2ce6/medium/brewdog-wonderland-cocktails.jpeg https://www.arkansashealthcarereport.com/article/912787126-climb-bio-to-present-new-budoprutug-clinical-data-at-european-hematology-association-eha-2026-congress Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg https://www.arkansashealthcarereport.com/article/912787131-cabaletta-bio-presents-preconditioning-free-clinical-data-and-automated-manufacturing-translational-data-for-rese-cel-at-asgct-2026-annual-meeting Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting https://ml.globenewswire.com/media/44175396-6bbb-435f-b037-54a4052160d4/small/cabaletta-bio-registered-logo-png.png https://www.arkansashealthcarereport.com/article/912787163-pelthos-therapeutics-announces-first-quarter-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Pelthos Therapeutics Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/7d71f2d0-a48f-4fe0-a49c-138de21bc0e1/small/pelthos-logo-rgb-png.png https://www.arkansashealthcarereport.com/article/912787184-hyperion-defi-reports-1q-2026-financial-results-with-record-net-income-and-raises-guidance-for-full-year-2026 Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Hyperion DeFi Reports 1Q 2026 Financial Results with Record Net Income and Raises Guidance for Full Year 2026 https://ml.globenewswire.com/media/ddd4c6f1-b02c-49f1-90c3-46e511620d60/medium/hyperion-generates-independent-scaling-businesses-on-hyperli.png https://www.arkansashealthcarereport.com/article/912787191-pyxis-oncology-reports-first-quarter-2026-financial-results-and-advances-micvo-toward-key-2026-clinical-milestones Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912787280-corvus-pharmaceuticals-presents-soquelitinib-phase-1-atopic-dermatitis-data-at-the-society-for-investigative-dermatology-sid-annual-meeting Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting https://ml.globenewswire.com/media/1dfb622c-604b-4e02-9d90-d36c6719bfa1/medium/figure-1.jpg https://www.arkansashealthcarereport.com/article/912787316-larimar-therapeutics-reports-first-quarter-2026-financial-and-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update https://ml.globenewswire.com/media/b02e1010-493d-4ec7-8523-c59602684d09/small/lrmr-logo-png.png https://www.arkansashealthcarereport.com/article/912787569-profound-to-showcase-tulsa-pro-the-tulsa-procedure-and-the-future-of-imri-at-aua2026 Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026 https://ml.globenewswire.com/media/94d9e057-9de3-430c-9a19-b41ff3e06a1e/small/profound-logo-cmyk-copy-jpg.jpg https://www.arkansashealthcarereport.com/article/912787625-nrx-pharmaceuticals-inc-nasdaq-nrxp-to-report-first-quarter-2026-financial-results-and-provide-corporate-update Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png https://www.arkansashealthcarereport.com/article/912787647-cyclarity-unveils-first-ever-clinical-data-demonstrating-excretion-of-oxidized-cholesterol-at-american-heart-association-vascular-discovery Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions https://ml.globenewswire.com/media/df1bfc3d-a35a-46d9-8610-a19a1c7c8ede/medium/cyclarity-co-founders-dr-amelia-anderson-matthew-oconnor-and.jpg https://www.arkansashealthcarereport.com/article/912787739-camp4-therapeutics-to-present-new-preclinical-data-demonstrating-cmp-002-improves-seizure-threshold-and-severity-in-a-model-of-syngap1-related Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg https://www.arkansashealthcarereport.com/article/912787743-xortx-announces-us-5-million-public-offering Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 XORTX Announces US$5 Million Public Offering https://ml.globenewswire.com/media/9898c4f8-b373-438a-abfa-709c4372a061/small/xortx-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912787908-tiziana-reports-reduced-brain-inflammation-in-multiple-system-atrophy-patients-treated-with-intranasal-foralumab Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab https://ml.globenewswire.com/media/99d6ad08-520b-4053-84a7-6a378f6a1aca/medium/figure-1-2nd-msa-patient-on-nasal-foralumab.png https://www.arkansashealthcarereport.com/article/912788051-gh-research-reports-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T11:00:00+00:00 GH Research Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/a1baa9e5-3408-4f8f-b4aa-7c4204e0971b/small/full-colour-png.png https://www.arkansashealthcarereport.com/article/912787248-topline-results-from-phase-2-celia-study-of-diranersen-biib080-first-study-to-show-reduction-in-tau-pathology-and-cognitive-benefit-in-patients Arkansas Healthcare Report en PressRelease 2026-05-14T10:59:00+00:00 Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://www.arkansashealthcarereport.com/article/912767803-fennec-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-14T10:30:00+00:00 Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/2eeb9b85-0beb-4bbe-a7af-1c0e9403db44/small/fennec-logo-png.png https://www.arkansashealthcarereport.com/article/912767795-editas-medicine-reports-new-preclinical-data-demonstrating-progress-of-edit-401-as-potential-treatment-for-hyperlipidemia-at-the-american-society-of Arkansas Healthcare Report en PressRelease 2026-05-14T10:01:00+00:00 Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg https://www.arkansashealthcarereport.com/article/912734188-ipsen-unveils-corabotase-a-first-in-class-recombinant-neuroinhibitor-rni-at-the-scale-symposium Arkansas Healthcare Report en PressRelease 2026-05-14T05:30:00+00:00 Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, RNI™, at the SCALE Symposium https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ipsen-notified-website-1200x628pix-500kb-max-jpg.jpg https://www.arkansashealthcarereport.com/article/912734190-ipsen-pr-sente-la-corabotase-un-neuro-inhibiteur-recombinant-rni-premier-de-sa-classe-lors-du-symposium-scale Arkansas Healthcare Report en PressRelease 2026-05-14T05:30:00+00:00 Ipsen présente la corabotase, un neuro-inhibiteur recombinant (RNI™) « premier de sa classe », lors du symposium SCALE https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ https://www.arkansashealthcarereport.com/article/912711965-fangzhou-and-tenry-pharmaceutical-forge-strategic-partnership-to-advance-ai-powered-chronic-disease-care Arkansas Healthcare Report en PressRelease 2026-05-14T03:21:29+00:00 Fangzhou and Tenry Pharmaceutical Forge Strategic Partnership to Advance AI-Powered Chronic Disease Care https://ml.globenewswire.com/media/e3ea81dc-4701-40e3-a0cd-505d016f2c8e/medium/fangzhou-and-tenry-pharmaceutical-forge-strategic-partnershi.jpg https://www.arkansashealthcarereport.com/article/912685521-propanc-biopharma-implements-reverse-stock-split-to-support-continued-nasdaq-listing-and-growth-plans Arkansas Healthcare Report en PressRelease 2026-05-14T02:00:00+00:00 Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans https://ml.globenewswire.com/media/0de2a486-4708-45bf-a406-f462ad395dec/small/propanc-logo-png.png https://www.arkansashealthcarereport.com/article/912685651-memopezil-under-investigation-evaluating-the-claims-risks-and-hidden-official-website-complaints-about-the-natural-donepezil-cocoa-and-honey Arkansas Healthcare Report en PressRelease 2026-05-14T01:09:43+00:00 Memopezil Under Investigation: Evaluating the Claims, Risks and Hidden Official Website Complaints about the Natural Donepezil Cocoa and Honey Protocol https://zingfast.com/wp-content/uploads/2026/05/Memopezil.jpg https://www.arkansashealthcarereport.com/article/912657246-jellytide-claims-evaluated-the-gelatin-trick-recipe-baking-soda-shot-with-lemon-for-weight-loss-using-jelly-tide-gummies Arkansas Healthcare Report en PressRelease 2026-05-14T00:21:29+00:00 JellyTide Claims Evaluated: The Gelatin Trick Recipe + Baking Soda Shot with Lemon for Weight Loss Using Jelly Tide Gummies https://zingfast.com/wp-content/uploads/2026/05/Jelly-Tide.jpg https://www.arkansashealthcarereport.com/article/912630093-hard-chews-gummies-claims-evaluated-investigating-the-salt-tonic-trick-recipe-for-men Arkansas Healthcare Report en PressRelease 2026-05-13T22:20:56+00:00 Hard Chews Gummies Claims Evaluated: Investigating the Salt Tonic Trick Recipe for Men https://zingfast.com/wp-content/uploads/2026/05/Hard-Chews-Gummies.jpg https://www.arkansashealthcarereport.com/article/912629993-venus-concept-announces-senior-management-changes Arkansas Healthcare Report en PressRelease 2026-05-13T21:25:00+00:00 Venus Concept Announces Senior Management Changes https://ml.globenewswire.com/media/e2cc3ec5-573b-4f8d-958f-718d93099bbd/small/image001-png.png https://www.arkansashealthcarereport.com/article/912629515-management-team-s-2025-market-based-options-have-vested Arkansas Healthcare Report en PressRelease 2026-05-13T21:00:00+00:00 Management team’s 2025 market-based Options have vested https://ml.globenewswire.com/media/d80ae417-b29a-4736-afa2-0f5e3beae51b/small/prpo-logo-png.png https://www.arkansashealthcarereport.com/article/912629601-aptose-reports-first-quarter-2026-results Arkansas Healthcare Report en PressRelease 2026-05-13T21:00:00+00:00 Aptose Reports First Quarter 2026 Results  https://ml.globenewswire.com/media/3f4ab307-5947-4ef1-b5b5-c2c66933728a/small/aptose-biosciences-inc-logo.jpg https://www.arkansashealthcarereport.com/article/912629618-zyversa-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-13T20:55:00+00:00 ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg https://www.arkansashealthcarereport.com/article/912603282-reviva-reports-first-quarter-2026-financial-results-and-recent-business-highlights Arkansas Healthcare Report en PressRelease 2026-05-13T20:35:00+00:00 Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/1d8c6564-1da5-4561-b6ec-79de6d565869/small/reviva-logo-png.png https://www.arkansashealthcarereport.com/article/912602104-edap-focal-one-to-host-investor-day-on-june-1-2026 Arkansas Healthcare Report en PressRelease 2026-05-13T20:30:00+00:00 EDAP | Focal One to Host Investor Day on June 1, 2026 https://ml-eu.globenewswire.com/media/MDU2NTQwZmMtODU5MC00OGU3LWE3NmQtNzc1NDg4ZDgxMDIxLTEwMzg1NTEtMjAyNi0wNS0xMy1lbg==/tiny/EDAP-TMS-S-A-.png https://www.arkansashealthcarereport.com/article/912602118-combined-general-meeting-of-june-3-2026 Arkansas Healthcare Report en PressRelease 2026-05-13T20:30:00+00:00 Combined General Meeting of June 3, 2026 https://ml-eu.globenewswire.com/media/274bd0ae-19c4-4821-85ce-7fe85ee610b5/small/logo1-jpg.jpg https://www.arkansashealthcarereport.com/article/912602144-assembl-e-g-n-rale-mixte-du-3-juin-2026 Arkansas Healthcare Report en PressRelease 2026-05-13T20:30:00+00:00 Assemblée Générale Mixte du 3 juin 2026 https://ml-eu.globenewswire.com/media/274bd0ae-19c4-4821-85ce-7fe85ee610b5/small/ https://www.arkansashealthcarereport.com/article/912602850-precision-optics-reports-third-quarter-fiscal-year-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-13T20:30:00+00:00 Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results https://ml.globenewswire.com/media/6d86ce33-7e41-41e5-90b0-1c74cd89785e/small/precision-optics-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912603254-park-dental-partners-announces-first-quarter-2026-results Arkansas Healthcare Report en PressRelease 2026-05-13T20:30:00+00:00 Park Dental Partners Announces First Quarter 2026 Results https://ml.globenewswire.com/media/48fd5730-f848-4991-96db-3d4db3274d34/small/pdp-rgb-jpg.jpg https://www.arkansashealthcarereport.com/article/912603349-rapid-micro-biosystems-reports-first-quarter-2026-financial-results Arkansas Healthcare Report en PressRelease 2026-05-13T20:25:58+00:00 Rapid Micro Biosystems Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/12585575-0b2e-4369-bf15-500b17ccb859/small/rapid-micro-biosystems-logo.png https://www.arkansashealthcarereport.com/article/912603310-tango-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-highlights Arkansas Healthcare Report en PressRelease 2026-05-13T20:07:25+00:00 Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights https://ml.globenewswire.com/media/d6e37a27-2e33-43bb-ae05-bfb0dedbf190/small/tango-logo-png.png https://www.arkansashealthcarereport.com/article/912602344-seer-reports-first-quarter-2026-financial-results-and-reaffirms-full-year-2026-outlook Arkansas Healthcare Report en PressRelease 2026-05-13T20:05:00+00:00 Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg https://www.arkansashealthcarereport.com/article/912602348-spero-therapeutics-announces-first-quarter-2026-operating-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-13T20:05:00+00:00 Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update https://ml.globenewswire.com/media/aad6f25c-1793-4870-a611-84ea3f25fed3/small/spero-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912602370-longeveron-announces-2026-first-quarter-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-13T20:05:00+00:00 Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update https://ml.globenewswire.com/media/cde71c09-a5f1-424d-837b-80f8786d82a5/medium/stephen-willard.jpg https://www.arkansashealthcarereport.com/article/912602376-wave-life-sciences-to-present-at-2026-rbc-capital-markets-global-healthcare-conference Arkansas Healthcare Report en PressRelease 2026-05-13T20:05:00+00:00 Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://www.arkansashealthcarereport.com/article/912602737-zentalis-pharmaceuticals-to-participate-in-upcoming-investor-conferences Arkansas Healthcare Report en PressRelease 2026-05-13T20:05:00+00:00 Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/ecb98bea-7a9f-4319-874c-1911777a5a46/small/zentalis-logo-full-color-png.png https://www.arkansashealthcarereport.com/article/912602843-vivani-medical-reports-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-13T20:05:00+00:00 Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/c63d8439-dc26-4ef7-af2c-4ec0db8feb4b/small/vivani-medical-600-jpg.jpg https://www.arkansashealthcarereport.com/article/912602863-bionano-reports-first-quarter-2026-results-and-provides-a-business-update Arkansas Healthcare Report en PressRelease 2026-05-13T20:05:00+00:00 Bionano Reports First Quarter 2026 Results and Provides a Business Update https://ml.globenewswire.com/media/5ba4072e-6e59-46e7-847c-6aaf7755bbbf/small/bionano-rgb-png.png https://www.arkansashealthcarereport.com/article/912602864-dyadic-announces-first-quarter-2026-financial-results-and-highlights-recent-company-progress Arkansas Healthcare Report en PressRelease 2026-05-13T20:05:00+00:00 Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress https://ml.globenewswire.com/media/c67f7901-660b-41c0-a160-0f92fd04bb42/small/dyadic-applied-biosolutions-jpg.jpg https://www.arkansashealthcarereport.com/article/912602873-imdx-reports-q1-2026-results-and-update-on-progress-toward-graftassure-commercialization Arkansas Healthcare Report en PressRelease 2026-05-13T20:05:00+00:00 IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization https://ml.globenewswire.com/media/418fe8d1-a6a4-4025-84ba-56f14ee83865/small/imdx-logo-png.png https://www.arkansashealthcarereport.com/article/912602912-logicmark-inc-announces-strong-first-quarter-2026-results Arkansas Healthcare Report en PressRelease 2026-05-13T20:05:00+00:00 LogicMark, Inc. Announces Strong First Quarter 2026 Results https://ml.globenewswire.com/media/a0f92be7-890f-496e-8c58-fc6621df90b0/small/logicmark-primary-color-png.png https://www.arkansashealthcarereport.com/article/912603286-eledon-pharmaceuticals-reports-first-quarter-2026-financial-results-and-recent-business-highlights Arkansas Healthcare Report en PressRelease 2026-05-13T20:05:00+00:00 Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/5e2f90ec-c9a5-4fcd-99c8-2c8c838ac033/small/eledon-logo-1230-png.png https://www.arkansashealthcarereport.com/article/912603280-oruka-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Arkansas Healthcare Report en PressRelease 2026-05-13T20:03:27+00:00 Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/3950d2d7-850d-459a-9e42-07c642a841c5/small/oruka-full-color-jpg.jpg https://www.arkansashealthcarereport.com/article/912602284-allogene-therapeutics-reports-first-quarter-2026-financial-results-and-business-update Arkansas Healthcare Report en PressRelease 2026-05-13T20:02:00+00:00 Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.arkansashealthcarereport.com/article/912602246-equillium-reports-first-quarter-2026-financial-results-and-corporate-highlights Arkansas Healthcare Report en PressRelease 2026-05-13T20:01:00+00:00 Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights https://ml.globenewswire.com/media/14ce766d-e697-461f-a27c-c1ee49c0eeff/small/equillium-logo-360x180-jpg.jpg https://www.arkansashealthcarereport.com/article/912602315-vtv-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Arkansas Healthcare Report en PressRelease 2026-05-13T20:01:00+00:00 vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/27198d2d-fdd5-4f74-8f54-7a9e5876e06d/small/vtv-therapeutics-color-jpg.jpg https://www.arkansashealthcarereport.com/article/912602559-journey-medical-corporation-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights Arkansas Healthcare Report en PressRelease 2026-05-13T20:01:00+00:00 Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights https://ml.globenewswire.com/media/68f0b467-248f-4250-9cda-2c7a68a11a1d/small/journeylogo-1-jpg.jpg https://www.arkansashealthcarereport.com/article/912602602-atyr-pharma-to-participate-in-upcoming-investor-conferences Arkansas Healthcare Report en PressRelease 2026-05-13T20:01:00+00:00 aTyr Pharma to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/d9b4b478-f8bd-4014-91ed-429caab67931/small/atyr-logo-png.png https://www.arkansashealthcarereport.com/article/912602885-macrogenics-reports-first-quarter-2026-financial-results-and-highlights-business-transformation Arkansas Healthcare Report en PressRelease 2026-05-13T20:01:00+00:00 MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation https://ml.globenewswire.com/media/9b9481ff-ca9f-4a5a-aa38-0ff57a087856/small/macrogenics-logo-rgb-fullcolor-png.png https://www.arkansashealthcarereport.com/article/912603245-aquestive-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Arkansas Healthcare Report en PressRelease 2026-05-13T20:01:00+00:00 Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/e0b65f93-9565-43d7-a6ff-88b8cbd6adea/small/aquestive-jpg.jpg https://www.arkansashealthcarereport.com/article/912603264-medicenna-announces-the-launch-of-a-marketed-public-offering-of-securities Arkansas Healthcare Report en PressRelease 2026-05-13T20:01:00+00:00 Medicenna Announces the Launch of a Marketed Public Offering of Securities https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png https://www.arkansashealthcarereport.com/article/912602086-mdxhealth-reports-q1-2026-results Arkansas Healthcare Report en PressRelease 2026-05-13T20:00:00+00:00 Mdxhealth Reports Q1-2026 Results https://ml-eu.globenewswire.com/media/695db10e-2b5a-44e3-af73-a3dea1ead37c/small/mdxhealth-logo-full-color-rgb-png.png